Search by Drug Name or NDC

    NDC 00597-0595-20 Adalimumab-adbm Details

    Adalimumab-adbm

    Adalimumab-adbm is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is .

    Product Information

    NDC 00597-0595
    Product ID 0597-0595_91b92321-8a46-4cdf-b124-746adc907a19
    Associated GPIs
    GCN Sequence Number 077687
    GCN Sequence Number Description adalimumab-adbm SYRINGEKIT 40MG/0.8ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 43789
    HICL Sequence Number 044481
    HICL Sequence Number Description ADALIMUMAB-ADBM
    Brand/Generic Generic
    Proprietary Name Adalimumab-adbm
    Proprietary Name Suffix n/a
    Non-Proprietary Name Adalimumab-adbm
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761058
    Listing Certified Through 2024-12-31

    Package

    NDC 00597-0595-20 (00597059520)

    NDC Package Code 0597-0595-20
    Billing NDC 00597059520
    Package 2 KIT in 1 CARTON (0597-0595-20) / 1 KIT in 1 KIT * 1 mL in 1 PACKET * 1 SYRINGE in 1 TRAY (0597-0590-26) / .8 mL in 1 SYRINGE
    Marketing Start Date 2023-10-01
    NDC Exclude Flag N
    Pricing Information N/A